Institutional Conflict of Interest Management and Monitoring Plan: RadioPharm VenturesTechnology Commercialization Agreement • November 7th, 2024
Contract Type FiledNovember 7th, 2024The University of Texas MD Anderson (MD Anderson) and RadioPharm Ventures (RV) are parties to a Technology Commercialization Agreement (Agreement). The Agreement will comprise of targets identified by MD Anderson using state-of-the art mass-spectrometry proteomic techniques. RadioPharm Ventures was created as a joint venture between MD Anderson and Radiopharm Theranostics Ltd.